Zein E. Obagi

WALDENCAST ALERT: Bragar Eagel & Squire, P.C. is Investigating Waldencast plc on Behalf of Waldencast Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, November 14, 2023
Sale, P.C, Bank statement, WALD, Annual report, Telephone, News, Zein E. Obagi, Life insurance

NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Waldencast plc (“Waldencast” or the “Company”) (NASDAQ: WALD) on behalf of Waldencast stockholders.

Key Points: 
  • NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Waldencast plc (“Waldencast” or the “Company”) (NASDAQ: WALD) on behalf of Waldencast stockholders.
  • Our investigation concerns whether Waldencast has violated the federal securities laws and/or engaged in other unlawful business practices.
  • Specifically, the Company is conducting an analysis regarding certain accounting issues in connection with the sale of certain Obagi products for the Vietnam market.
  • On this news, the price of Waldencast shares declined by $0.57 per share, or approximately 6.20%, from $9.20 per share to close at $8.63 on April 25, 2023.

Waldencast’s (WALD) stock sinks after copping to inflating revenues- Hagens Berman

Retrieved on: 
Tuesday, November 7, 2023
Bank statement, Person, SPAC, Sale, Hagens Berman, WALD, FYE, Cosmeceutical, Book, Pharmaceutical industry, Cryptocurrency, Life insurance, Zein E. Obagi

Most recently, on July 5, 2023, Waldencast announced that it would restate financial statements for the year ended December 31, 2021, and for the quarterly periods ended Mar.

Key Points: 
  • Most recently, on July 5, 2023, Waldencast announced that it would restate financial statements for the year ended December 31, 2021, and for the quarterly periods ended Mar.
  • 31, 2022 and June 30, 2022 as a result of improper revenue recognition involving Obagi sales to its Southeast Asia distributor.
  • “We’re focused on investors’ losses and whether Waldencast cooked its books,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation – WALD, WALDW

Retrieved on: 
Tuesday, November 7, 2023
Titan, WALD, News, I-Space (Chinese company), Advertising, Bank statement, Security (finance), Cryptocurrency, Zein E. Obagi

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=18362 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=18362 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc – WALD

Retrieved on: 
Sunday, November 5, 2023
WALD, Milk, Zein E. Obagi, News, Bank statement, Pomerantz, LLP, Proxy, Private investigator

NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc.

Key Points: 
  • NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc.
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Waldencast and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation – WALD, WALDW

Retrieved on: 
Saturday, November 4, 2023
Titan, WALD, News, I-Space (Chinese company), Advertising, Bank statement, Security (finance), Cryptocurrency, Zein E. Obagi

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=18362 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=18362 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Waldencast’s (WALD) stock sinks after copping to inflating revenues- Hagens Berman

Retrieved on: 
Monday, October 30, 2023
Person, SPAC, Sale, WALD, Cosmeceutical, Bank statement, FYE, Hagens Berman, Book, SAN, Cryptocurrency, Pharmaceutical industry, Life insurance, Zein E. Obagi

SAN FRANCISCO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Waldencast plc (NASDAQ: WALD) investors who suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Waldencast plc (NASDAQ: WALD) investors who suffered substantial losses to submit your losses now .
  • Most recently, on July 5, 2023, Waldencast announced that it would restate financial statements for the year ended December 31, 2021, and for the quarterly periods ended Mar.
  • 31, 2022 and June 30, 2022 as a result of improper revenue recognition involving Obagi sales to its Southeast Asia distributor.
  • “We’re focused on investors’ losses and whether Waldencast cooked its books,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc – WALD

Retrieved on: 
Friday, October 27, 2023
WALD, Milk, Zein E. Obagi, News, Bank statement, Pomerantz, LLP, Proxy, Cryptocurrency, Private investigator

NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc.

Key Points: 
  • NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc.
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Waldencast and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Waldencast plc (WALD) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Monday, October 23, 2023
Person, SPAC, Sale, WALD, Cosmeceutical, Bank statement, FYE, Hagens Berman, Book, SAN, Cryptocurrency, Pharmaceutical industry, Life insurance, Zein E. Obagi

SAN FRANCISCO, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Waldencast plc (NASDAQ: WALD) investors who suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Waldencast plc (NASDAQ: WALD) investors who suffered substantial losses to submit your losses now .
  • Most recently, on July 5, 2023, Waldencast announced that it would restate financial statements for the year ended December 31, 2021, and for the quarterly periods ended Mar.
  • 31, 2022 and June 30, 2022 as a result of improper revenue recognition involving Obagi sales to its Southeast Asia distributor.
  • “We’re focused on investors’ losses and whether Waldencast cooked its books,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc – WALD

Retrieved on: 
Thursday, October 19, 2023
WALD, Milk, Zein E. Obagi, News, Bank statement, Pomerantz, LLP, Proxy, Cryptocurrency, Private investigator

NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc.

Key Points: 
  • NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc.
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Waldencast and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

“Waldencast’s (WALD) stock sinks after copping to inflating revenues,” Hagens Berman

Retrieved on: 
Monday, October 16, 2023
FYE, WALD, Bank statement, Book, Cosmeceutical, Person, SAN, SPAC, Hagens Berman, Sale, Cryptocurrency, Pharmaceutical industry, Zein E. Obagi

SAN FRANCISCO, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Waldencast plc (NASDAQ: WALD) investors who suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Waldencast plc (NASDAQ: WALD) investors who suffered substantial losses to submit your losses now .
  • 31, 2022 and June 30, 2022 as a result of improper revenue recognition involving Obagi sales to its Southeast Asia distributor.
  • “We’re focused on investors’ losses and whether Waldencast cooked its books,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Waldencast and have substantial losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .